News
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for ...
The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...
The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...
Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...
Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...
Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results